These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

592 related articles for article (PubMed ID: 22392529)

  • 41. Response to cardiac resynchronization therapy: substrate matters.
    Needleman M; Berger RD
    Heart Rhythm; 2011 Mar; 8(3):383-4. PubMed ID: 21167316
    [No Abstract]   [Full Text] [Related]  

  • 42. Inverse Relationship of Blood Pressure to Long-Term Outcomes and Benefit of Cardiac Resynchronization Therapy in Patients With Mild Heart Failure: A Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy Long-Term Follow-Up Substudy.
    Biton Y; Moss AJ; Kutyifa V; Mathias A; Sherazi S; Zareba W; McNitt S; Polonsky B; Barsheshet A; Brown MW; Goldenberg I
    Circ Heart Fail; 2015 Sep; 8(5):921-6. PubMed ID: 26179186
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quality of life predicting long-term outcomes in cardiac resynchronization therapy patients.
    Nagy KV; Merkely B; Rosero S; Geller L; Kosztin A; McNitt S; Polonsky B; Goldenberg I; Zareba W; Kutyifa V
    Europace; 2019 Dec; 21(12):1865-1875. PubMed ID: 31617896
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Novel non-pharmacological approaches to heart failure.
    Abraham WT; De Ferrari GM
    J Cardiovasc Transl Res; 2014 Apr; 7(3):263-5. PubMed ID: 24671656
    [No Abstract]   [Full Text] [Related]  

  • 45. 2010 Focused Update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association.
    Dickstein K; Vardas PE; Auricchio A; Daubert JC; Linde C; McMurray J; Ponikowski P; Priori SG; Sutton R; van Veldhuisen DJ;
    Eur Heart J; 2010 Nov; 31(21):2677-87. PubMed ID: 20801924
    [No Abstract]   [Full Text] [Related]  

  • 46. Journey Through Advanced Heart Failure: A Family Affair.
    Wilcox JE
    Circ Heart Fail; 2019 Nov; 12(11):e006393. PubMed ID: 31684755
    [No Abstract]   [Full Text] [Related]  

  • 47. ICD Versus CRT-D Implantation: Is Age Really Just a Number?
    Atwater BD; Yousuf OK
    JACC Heart Fail; 2022 Mar; 10(3):158-160. PubMed ID: 35033461
    [No Abstract]   [Full Text] [Related]  

  • 48. Baseline functional capacity and the benefit of cardiac resynchronization therapy in patients with mildly symptomatic heart failure enrolled in MADIT-CRT.
    Brenyo A; Goldenberg I; Moss AJ; Rao M; McNitt S; Huang DT; Zareba W; Barsheshet A
    Heart Rhythm; 2012 Sep; 9(9):1454-9. PubMed ID: 22521920
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Complex Decision-Making in Heart Failure: A Systematic Review and Thematic Analysis.
    Hamel AV; Gaugler JE; Porta CM; Hadidi NN
    J Cardiovasc Nurs; 2018; 33(3):225-231. PubMed ID: 29232275
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Shared Decision-Making and Cardiovascular Health: A Scientific Statement From the American Heart Association.
    Dennison Himmelfarb CR; Beckie TM; Allen LA; Commodore-Mensah Y; Davidson PM; Lin G; Lutz B; Spatz ES; ;
    Circulation; 2023 Sep; 148(11):912-931. PubMed ID: 37577791
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cardiac resynchronization therapy in women: US Food and Drug Administration meta-analysis of patient-level data.
    Zusterzeel R; Selzman KA; Sanders WE; Caños DA; O'Callaghan KM; Carpenter JL; Piña IL; Strauss DG
    JAMA Intern Med; 2014 Aug; 174(8):1340-8. PubMed ID: 25090172
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Health Literacy Mediates the Relationship Between Age and Health Outcomes in Patients With Heart Failure.
    Wu JR; Moser DK; DeWalt DA; Rayens MK; Dracup K
    Circ Heart Fail; 2016 Jan; 9(1):e002250. PubMed ID: 26721913
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of America: This statement does not represent an update of the 2017 ACC/AHA/HFSA heart failure guideline update.
    Dunlay SM; Givertz MM; Aguilar D; Allen LA; Chan M; Desai AS; Deswal A; Dickson VV; Kosiborod MN; Lekavich CL; McCoy RG; Mentz RJ; Piña IL;
    Circulation; 2019 Aug; 140(7):e294-e324. PubMed ID: 31167558
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Remote Hemodynamic-Guided Therapy of Patients With Recurrent Heart Failure Following Cardiac Resynchronization Therapy.
    Varma N; Bourge RC; Stevenson LW; Costanzo MR; Shavelle D; Adamson PB; Ginn G; Henderson J; Abraham WT;
    J Am Heart Assoc; 2021 Feb; 10(5):e017619. PubMed ID: 33626889
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 20 years of cardiac resynchronization therapy.
    Leyva F; Nisam S; Auricchio A
    J Am Coll Cardiol; 2014 Sep; 64(10):1047-58. PubMed ID: 25190241
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cardiac resynchronization therapy-defibrillator improves long-term survival compared with cardiac resynchronization therapy-pacemaker in patients with a class IA indication for cardiac resynchronization therapy: data from the Contak Italian Registry.
    Morani G; Gasparini M; Zanon F; Casali E; Spotti A; Reggiani A; Bertaglia E; Solimene F; Molon G; Accogli M; Tommasi C; Paoletti Perini A; Ciardiello C; Padeletti L
    Europace; 2013 Sep; 15(9):1273-9. PubMed ID: 23439866
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cardiac resynchronization therapy improves psycho-cognitive performance in patients with heart failure.
    Duncker D; Friedel K; König T; Schreyer H; Lüsebrink U; Duncker M; Oswald H; Klein G; Gardiwal A
    Europace; 2015 Sep; 17(9):1415-21. PubMed ID: 25745071
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cardiac Resynchronization Therapy: How to Decrease Nonresponders.
    Tolosana JM; Mont L
    Card Electrophysiol Clin; 2015 Dec; 7(4):789-96. PubMed ID: 26596820
    [TBL] [Abstract][Full Text] [Related]  

  • 59. When is an implantable cardioverter-defibrillator controversial?
    Coats AJS
    Eur J Heart Fail; 2019 Dec; 21(12):1504-1506. PubMed ID: 31414559
    [No Abstract]   [Full Text] [Related]  

  • 60. Interaction of Left Ventricular Remodeling and Regional Dyssynchrony on Long-Term Prognosis after Cardiac Resynchronization Therapy.
    Tayal B; Sogaard P; Delgado-Montero A; Goda A; Saba S; Risum N; Gorcsan J
    J Am Soc Echocardiogr; 2017 Mar; 30(3):244-250. PubMed ID: 27986357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.